Different Susceptibilities of Postmitotic Checkpoint-proficient and-deficient Balb/3T3 Cells to ICRF-193, a Catalytic Inhibitor of DNA Topoisomerase II

スポンサーリンク

概要

論文の詳細を見る
2001-02-28

著者

関連論文

BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32
Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma : A Japan Clinical Oncology Group Study, JCOG 9301
Gastric low-grade B-cell MALT lymphoma : treatment, response, and genetic alteration
Clinicopathologic Comparison between the API2-MALT1 Chimeric Transcriptpositive and -negative Gastric low-grade B-Cell Lymphoma of Mucosa-associated Lymphoid Tissue Type
Therapy-Related Leukemia and Myelodysplastic Syndrome: A Large-scale Japanese Study of Clinical and Cytogenetic Features as Well as Prognostic Factors
Expression profiling analysis of the CD5^+ diffuse large B-cell lymphoma subgroup : Development of a CD5 signature
Characterization of target genes at the 2p15-16 amplicon in diffuse large B-cell lymphoma
Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
Comparison of genetic aberrations in CD10^+ diffused large B-cell lymphoma and follicular lymphoma by comparative genomic hybridization and tissue-fluorescence in situ hybridization
MUM1/IRF4 Expression Is an Unfavorable Prognostic Factor in B-Cell Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma(SLL)
Activation of Caspase-3, Proteolytic Cleavage of DFF and No Oligonucleosomal DNA Fragmentation in Apoptotic Molt-4 Cells
Zinc Induces Mixed Types of Cell Death, Necrosis, and Apoptosis, in Molt-4 Cells^1
Gain-of-function mutations and copy number increases of Notch2 in diffuse large B-cell lymphoma
Letters to the editor
Immunity against mouse thymus-leukemia antigen (TL) protects against development of lymphomas induced by a chemical carcinogen, N-butyl-N-nitrosourea
Thymus leukemia antigen (TL)-specific cytotoxic T lymphocytes recognize the α1/α2 domain of TL free from antigenic peptides
Prognostic significance of genetic alterations detected by high-density single nucleotide polymorphism array in gastric cancer
Multiple fuzzy neural network system for outcome prediction and classification of 220 lymphoma patients on the basis of molecular profiling
Selection of Causal Gene Sets for Lymphoma Prognostication from Expression Profiling and Construction of Prognostic Fuzzy Neural Network Models(MEDICAL BIOTECHNOLOGY)
Fuzzy Neural Network Applied to Gene Expression Profiling for Predicting the Prognosis of Diffuse Large B-cell Lymphoma
Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development
Different Susceptibilities of Postmitotic Checkpoint-proficient and-deficient Balb/3T3 Cells to ICRF-193, a Catalytic Inhibitor of DNA Topoisomerase II
Genetic and epigenetic factors involved in B-cell lymphomagenesis
Nuclear Factor κB Activation and Antiapoptosis in Mucosa-Associated Lymphoid Tissue Lymphoma
Diversity of genome profiles in malignant lymphoma
Dual antitumor mechanisms of Notch signaling inhibitor in a T-cell acute lymphoblastic leukemia xenograft model
A genetic polymorphism of CYP2C19 is associated with susceptibility to biliary tract cancer
Genomic profiles in B cell lymphoma
Different subtypes of intraductal papillary mucinous neoplasm in the pancreas have distinct pathways to pancreatic cancer progression

もっと見る

スポンサーリンク